文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

嗅神经母细胞瘤分期匹配的内镜手术与开放手术切除的生存结果

Survival outcomes for stage-matched endoscopic and open resection of olfactory neuroblastoma.

作者信息

Harvey Richard J, Nalavenkata Sunny, Sacks Raymond, Adappa Nithin D, Palmer James N, Purkey Michael T, Schlosser Rodney J, Snyderman Carl, Wang Eric W, Woodworth Bradford A, Smee Robert, Havas Tom, Gallagher Richard

机构信息

Applied Medical Research Centre, University of New South Wales, Kensington, Australia.

Faculty of Medicine and Health Sciences, Macquarie University, New South Wales, Australia.

出版信息

Head Neck. 2017 Dec;39(12):2425-2432. doi: 10.1002/hed.24912. Epub 2017 Sep 25.


DOI:10.1002/hed.24912
PMID:28945299
Abstract

BACKGROUND: Advanced-stage olfactory neuroblastoma requires multimodal therapy for optimal outcomes. Debate exists over endoscopic endonasal surgery in this situation. Stage-matched open and endoscopic surgical therapy were compared. METHODS: Patients from 6 cancer institutions were assessed. Stratification included dural involvement, Kadish stage, nodal disease, Hyams' grade, approach, and margin status. At follow-up, local control, nodal status, and evidence of distant metastases were recorded with any subsequent therapy. Statistical analyses to identify risk factors for developing recurrence and survival differences were performed. RESULTS: One hundred nine patients were assessed (age 49.2 ± 13.0 years; 46% women) representing Kadish A stage (10%), Kadish B stage (25%), and Kadish C stage (65%). The majority of the patients (61.5%) underwent endoscopic resection, 53.5% within Kadish C stage. Within-stage survival analysis favored endoscopic subgroup for Kadish C stage (log-rank P = .017) nonsignificant for Kadish B stage (log-rank P = .39). CONCLUSION: Stage-matched survival was better for the endoscopically treated group compared to the open surgery group, with high negative margin resections obtained.

摘要

背景:晚期嗅神经母细胞瘤需要多模式治疗以获得最佳疗效。在这种情况下,对于鼻内镜下鼻内手术存在争议。对分期匹配的开放手术和内镜手术治疗进行了比较。 方法:对来自6家癌症机构的患者进行评估。分层包括硬脑膜受累情况、卡迪什分期、淋巴结疾病、海姆斯分级、手术入路和切缘状态。随访时,记录局部控制情况、淋巴结状态以及远处转移的证据和任何后续治疗。进行统计分析以确定复发的危险因素和生存差异。 结果:评估了109例患者(年龄49.2±13.0岁;46%为女性),代表卡迪什A期(10%)、卡迪什B期(25%)和卡迪什C期(65%)。大多数患者(61.5%)接受了内镜下切除,其中53.5%处于卡迪什C期。分期内生存分析显示,卡迪什C期内镜亚组更具优势(对数秩检验P = 0.017),卡迪什B期无显著差异(对数秩检验P = 0.39)。 结论:与开放手术组相比,内镜治疗组的分期匹配生存率更高,且切缘阴性切除率高。

相似文献

[1]
Survival outcomes for stage-matched endoscopic and open resection of olfactory neuroblastoma.

Head Neck. 2017-12

[2]
Esthesioneuroblastoma and sinonasal undifferentiated carcinoma: impact of histological grading and clinical staging on survival and prognosis.

Laryngoscope. 2000-8

[3]
Endoscopic Endonasal Management of Olfactory Neuroblastoma: A Retrospective Analysis of 10 Patients with Quality-of-Life Measures.

World Neurosurg. 2016-6

[4]
Comparison of Open and Endoscopic Approaches in the Resection of Esthesioneuroblastoma.

Ann Otol Rhinol Laryngol. 2021-2

[5]
Endoscopic endonasal resection of esthesioneuroblastoma: A single center experience of 24 patients.

Clin Neurol Neurosurg. 2015-11

[6]
Long-term oncological outcome after endoscopic surgery for olfactory esthesioneuroblastoma.

Acta Otolaryngol. 2014-12

[7]
Endoscopic endonasal resection of esthesioneuroblastoma: a multicenter study.

Am J Rhinol Allergy. 2009

[8]
Utility of adjuvant chemotherapy in patients receiving surgery and adjuvant radiotherapy for primary treatment of esthesioneuroblastoma.

Head Neck. 2018-12-10

[9]
Outcomes and Quality-of-Life Measures after Endoscopic Endonasal Resection of Kadish Stage C Olfactory Neuroblastomas.

World Neurosurg. 2021-7

[10]
Comparing Kadish and Modified Dulguerov Staging Systems for Olfactory Neuroblastoma: An Individual Participant Data Meta-analysis.

Otolaryngol Head Neck Surg. 2020-4-14

引用本文的文献

[1]
Refinement of Hyams Grading Criteria for Olfactory Neuroblastoma in an Endoscopic Sinus Surgery Predominant Cohort with Extended Follow-up: Worth the Effort?

Head Neck Pathol. 2025-7-29

[2]
SIADH as an uncommon presentation of olfactory neuroblastoma: a case-based overview.

Endocr Oncol. 2025-7-7

[3]
Endoscopic surgery versus various open approaches in esthesioneuroblastoma: a systematic review of the literature.

Front Oncol. 2025-5-28

[4]
Surgical margin assessment and prognostic impact in sinonasal cancers: a systematic review and meta-analysis.

Acta Otorhinolaryngol Ital. 2025-5

[5]
Forty-Year Long-Term Outcome After Endoscopic and Open Surgery for Esthesioneuroblastoma in Consideration of Prognostic Factors.

Cancers (Basel). 2025-1-21

[6]
Esthesioneuroblastoma: 38 years of experience in an oncological center.

Rep Pract Oncol Radiother. 2024-6-6

[7]
Clinical outcomes for olfactory neuroblastoma.

Front Oncol. 2024-5-2

[8]
Personalized Approach to Olfactory Neuroblastoma Care.

J Pers Med. 2024-4-16

[9]
[Endoscopic endonasal anterior skull base surgery : Presentation of a monocentric entity profile].

HNO. 2024-4

[10]
Update on olfactory neuroblastoma.

Virchows Arch. 2024-4

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索